lobbying_activities: 2468350

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2468350	5b550962-4f81-4c53-9ec9-1d8f6a56d127	Q2	SUMMIT PUBLIC AFFAIRS	401105467	VANDA PHARMACEUTICALS INC.	2020	second_quarter	PHA	Issues affecting the pharmaceutical industry, including the prescription drug approval process, animal testing, and gastroparesis issues. Administration of the 21st Century Cares Act (Pub. L. No. 114-255). Administration of the Coronavirus Aid, Relief, and Economic Security (CARES) Act (Pub. L. No. 116-136). COVID-19 Clinical Trials. Agriculture, Rural Development, FDA, and Related Agencies Appropriations for FY2021, provisions regarding FDA testing for new drug applications.	HOUSE OF REPRESENTATIVES,SENATE	40000		0	0	2020-07-16T12:41:24.497000-04:00